27687-12-3

Basic information

• Product Name: Cyclohexanecarboxylic acid, 4-[[[(phenylmethoxy)carbonyl]amino]methyl]-, trans-
• CAS NO: 27687-12-3
• Molecular Formula: C16H21NO4
• Molecular Weight: 291.347
• Mol File: 27687-12-3.mol
• Article Data: 9

Chemical Properties

• CAS DataBase Reference: Cyclohexanecarboxylic acid, 4-[[[(phenylmethoxy)carbonyl]amino]methyl]-, trans-(CAS DataBase Reference)
• NIST Chemistry Reference: Cyclohexanecarboxylic acid, 4-[[[(phenylmethoxy)carbonyl]amino]methyl]-, trans-(27687-12-3)
• EPA Substance Registry System: Cyclohexanecarboxylic acid, 4-[[[(phenylmethoxy)carbonyl]amino]methyl]-, trans-(27687-12-3)

Safety Data

• Hazardous Substances Data: 27687-12-3(Hazardous Substances Data)

Upstream product

• 63438-65-3 C₁₇H₂₃NO₄ 
• 1197-18-8 trans-4-aminomethyl-cyclohexyl-carboxylic acid 
• 501-53-1 benzyl chloroformate 

Downstream Products

• 38688-32-3 (4-Diethylcarbamoyl-cyclohexylmethyl)-carbamic acid benzyl ester 
• 38688-30-1 [4-(2-Dimethylamino-ethylcarbamoyl)-cyclohexylmethyl]-carbamic acid benzyl ester 
• 936901-77-8 benzyl {[trans-4-(8-chloroimidazo[1,5-a]pyrazin-3-yl)cyclohexyl]methyl}carbamate 
• 936901-76-7 benzyl[(trans-4-{[(3-chloropyrazin-2-yl)methyl]carbamoyl}cyclohexyl)methyl]carbamate 
• 38690-25-4 Carboxymethyl-trans-4-aminomethylcyclohexan-carboxylat 
• 38688-43-6 4-[4-(Benzyloxycarbonylamino-methyl)-cyclohexanecarbonyloxy]-isophthalic acid dibenzyl ester 
• 38692-47-6 4-(Benzyloxycarbonylamino-methyl)-cyclohexanecarboxylic acid 4-(5-benzyloxycarbonyl-pentyl)-phenyl ester 
• 38688-50-5 3-[4-(Benzyloxycarbonylamino-methyl)-cyclohexanecarbonyloxy]-naphthalene-2-carboxylic acid benzyl ester 
• 38688-49-2 4-(Benzyloxycarbonylamino-methyl)-cyclohexanecarboxylic acid 4-(2-benzyloxycarbonyl-ethoxy)-phenyl ester 
• 38688-47-0 4-(Benzyloxycarbonylamino-methyl)-cyclohexanecarboxylic acid 4-(benzyloxycarbonylmethyl-amino)-phenyl ester 
• 38688-44-7 4-(Benzyloxycarbonylamino-methyl)-cyclohexanecarboxylic acid 4-(2-benzyloxycarbonyl-ethyl)-phenyl ester 
• 38688-58-3 4-(Benzyloxycarbonylamino-methyl)-cyclohexanecarboxylic acid 4-benzyloxycarbonylmethyl-phenyl ester 
• 38688-54-9 4-[4-(Benzyloxycarbonylamino-methyl)-cyclohexanecarbonyloxy]-3-nitro-benzoic acid methyl ester 

Relevant articles and documents

8-METHYL-1-PHENYL-IMIDAZOL[1,5-A]PYRAZINE COMPOUNDS

The present invention provides 8-methyl-1 -phenyl-imidazo[1,5-a]pyrazine derivatives according to formula I or pharmaceutically acceptable salts thereof. The compounds of the current invention show inhibitory activity against Lck and can be used for the treatment of Lck-mediated diseases or Lck-mediated conditions such as inflammatory disorders.

METHOD OF PREPARING DENDRITIC DRUGS

Synthetic design of drug-incorporated novel dendrimer structures for quantitatively controlled drug delivery. The dendritic drugs have better control and thus a quantitative drug release can be obtained. There are no prior art dendritic drugs that control release both sequentially and quantitatively like the dendritic drugs disclosed herein. The dendritic drugs are formed by incorporating multiple same type drug units or more than two different drug types into a dendritic cascade structure to form a dendrimer drug.

Discovery and evaluation of a series of 3-acylindole imidazopyridine platelet-activating factor antagonists

Studies conducted with the goal of discovering a second-generation platelet-activating factor (PAF) antagonist have identified a novel class of potent and orally active antagonists which have high aqueous solubility and long duration of action in animal m